Details

Goldman Sachs Global Healthcare Conference

Slide type

Single Chart

Description

Line chart comparing DURAVYU 2.7mg (excluding outlier) vs. aflibercept across 24 weeks. Annotated visual highlights the +2.8 mean difference.

Use Case

Product and Service Analysis

Industry

Healthcare & Pharmaceuticals

Tags

Line Chart

Please submit your feedback here.

Note: All slides are from public sources.

Continue browsing similar slides with a FREE account

Receive Instant Access to 8,000+ slides

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Have an account? Sign in

Instant access to the internet's best slides

Get access to 40+ advanced filters and more

Advanced Search and Filters

Access to 10,000+ slides

Access to Category Pages

Save/Bookmark Slides

PowerPoint Template Library (New)

Secured by Stripe | AES-256 bit encryption